• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
LTP 0.41% $1.23

LTR PHARMA LIMITED - Announcements

LTR Pharma Limited is an Australia-based clinical-stage biopharmaceutical company. The... LTR Pharma Limited is an Australia-based clinical-stage biopharmaceutical company. The Company is focused on holistically improving men’s health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction (ED). Its lead product SPONTAN is set apart from existing ED therapies by its mechanism of action-intranasal delivery technology of a PDE5 inhibitor. The nasal cavity is a highly vascular part of the body supporting even and rapid absorption of the drug, empowering it to work in 10 minutes or less. SPONTAN (SDS-089) is a novel intranasal drug (PDE5) delivery platform for Erectile Dysfunction. More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk

No announcements returned.

(20min delay)
Last
$1.23
Change
0.005(0.41%)
Mkt cap ! $150.0M
Open High Low Value Volume
$1.22 $1.27 $1.21 $414.2K 335.7K

Buyers (Bids)

No. Vol. Price($)
1 1708 $1.23
 

Sellers (Offers)

Price($) Vol. No.
$1.26 2000 1
View Market Depth
Last trade - 16.10pm 21/11/2024 (20 minute delay) ?
Last
$1.24
  Change
0.005 ( 1.42 %)
Open High Low Volume
$1.21 $1.26 $1.21 33659
Last updated 15.59pm 21/11/2024 ?
LTP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.